CONSUN PHARMACEUTICAL GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.83 HKD | +1.39% |
|
+4.11% | +22.22% |
| Jun. 21 | Consun Pharmaceutical Group Limited Announces Board and Committee Changes | CI |
| May. 31 | Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2023 | CI |
ETFs positioned on Consun Pharmaceutical Group Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 32 M€ | +5.19% | - |
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.351
CNY
Average target price
7.615
CNY
Spread / Average Target
+42.30%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +22.22% | 608M | |
| +25.88% | 44.74B | |
| +33.09% | 23.36B | |
| +25.68% | 16.24B | |
| +21.32% | 14.39B | |
| +69.10% | 13.96B | |
| -13.04% | 6.4B | |
| -8.87% | 5.73B | |
| +13.36% | 5.68B | |
| +12.06% | 4.92B |
- Stock Market
- Equities
- 1681 Stock
- ETFs Consun Pharmaceutical Group Limited
